The Santos lab will use the grant to take his prototype molecules and synthesize derivatives to enhance their effectiveness in treating NASH (nonalcoholic steatohepatitis), which is characterized by inflammation, fat accumulation, and scarring of the liver.
Webster Santos, Virginia Tech drug researcher receives $2.2 million NIH grant to further develop “fat burning” molecule
